Core Viewpoint - The company has experienced a decline in new orders due to temporary factors in the international environment, but has seen a significant increase in orders in the third quarter compared to the second quarter, indicating a positive outlook for future growth [1] Group 1: Market Demand and Competition - The decline in new signed orders is attributed to market demand factors and competition within the industry [1] - The company has adjusted its downstream layout in response to these challenges, leading to a noticeable increase in orders in the third quarter [1] Group 2: Industry Performance - The company achieved breakthroughs in the medical industry during the third quarter, continuing the growth momentum seen in the semiconductor and low-altitude economy sectors from the first half of the year [1] - The company has successfully established partnerships with new clients, contributing to a robust order backlog [1] Group 3: Future Outlook - The company remains confident in the market outlook, believing that the revenue scale and profitability will significantly improve once three expansion projects are officially put into operation [1]